The analysis of endothelial nitric oxide synthase gene polymorphism in intron 4 with hypertension disease by Zarmakhi, Leila & Hashemi, Mehrdad




The analysis of endothelial nitric oxide synthase gene polymorphism in intron 4 
with hypertension disease 
 




 Department of Genetics,Islamic azad university,Tehran medical branch,Tehran ,Iran 
 




      Nitric oxide is an important vasorelaxant factor that it inhibits platelet adhesion and proliferation of 
smooth muscle cells. NO is synthesized from L-arginine by means of endothelial nitric oxide synthase 
(eNOS) which is an isoform of  Nitric Oxide Synthase.In the present study, we examined  possible 
association between the 27 base pair (bp) repeat  polymorphism in intron 4 of the  eNOS3 gene and 
hypertension in an Iranian  population. 40 patients with hypertension and 40 healthy controls were included 
in the research.Genotyping was performed by polymorphism chain reaction (PCR). The frequency of 4a4a, 
4a4b , 4b4b  genotypes  were  52.6% , 26.3%,  15.7% respectively  in hypertension groups .The frequency of 
4a4a, 4a4b , 4b4b  genotypes  were 73.8% , 15.7% , 10.5% respectively  in   control  groups. The 
hypertensive patient group showed a significant higher frequency of the 4a allele compared to the controls 
(p<0.01).The present study showed a singificant  association between the eNOS3 gene polymorphism and 
hypertension in the Iranian population . 
 
Keywords:  Hypertension; Nitric oxide synthase gene; Polymorphism 
 
INTRODUCTION 
      Hypertension is a multifactorial disease 
involving both environmental and genetic 
components that their  pathogenic mechanisms 
haven’t been clear yet. Clinical and Experimental  
studies suggest that an alteration in nitric oxide 
(NO) metabolism is a feasible contributing factor 
in the pathogenesis of hypertension[1-3]. Nitric 
oxide (NO) is a gaseous free radical and an 
important molecular mediator of many 
physiologic processes in virtually every organ[4]. 
Nitric oxide in the cardiovascular system is an 
important vasorelaxant factor that it  also inhibits 
platelet adhesion and proliferation of smooth 
muscle cells[5].Endothelial nitric oxide synthase 
(eNOS) is one of three isoforms of nitric oxide 
synthase which exhibits homology of sequence 
and function[6]. NO is synthesized from L-
arginine by means of endothelial nitric oxide 
synthase (NOS), which is an isoform of Nitric 
Oxide Synthase(NOS), as well as  it is dominant 
in the blood vessel walls [4,7]. 
The gene encoding eNOS is located on 
chromosome 7(7q35-q36) and it contains 26 
exons with an entire length of 21 kb [4,8]. Some 
studies considered the role of endothelial NOS in 
hypertension was provided by the observation that 
disruption of the NOS3 gene in knockout mice 
resulted in increase blood pressure  [3]. 
Association studies of intron 4 of eNOS gene 27 
bp polymorphism and hypertension  disease have 
reported variable results [9-14]. This study is 
carried out in order to  show the association of 
intron 4 polymorphism of the NOS3 gene with the 
incidence of hypertension in Iran population . 
  
MATERIALS AND METHODS 
      80 subjects were enrolled in this study.They 
are included 40 hypertension patients (14 men and 
26 women ) with age average 61/78 and 40 
normotensive subjects (26 men and 13 women) 
with age average 44/15. Arterial hypertension was 
defined according to the criteria of the World 
Health Organization that they are included a 
systolic blood pressure and diastolic blood 




pressure of ≥ 140/90 mmhg [9]. Family history 
for early cardiovascular events were analyzed as 
previously reported [10]. Normal control subjects 
weren’t exposed to antihypertensive treatment and 
their SBP and DBP were less than 140 and 90 
mmhg, respectively. 
DNA analysis 
Genomic DNA was isolated from peripheral white 
blood cells by phenol-chloroform extraction and 
for genotyping was taken into EDTA-containing 
receptacies. The 27 base pair (bp) repeat 
polymorphism in intron 4 of the eNOS3 gene was 
analyzed with polymerase chain reaction followed 
by the method of Wang et al(15). Oligonucleotide 
primers of PCR were designed as follows: sense 
5’-AGG CCC TAT GGT AGT GCA TTT-3’ and 
antisense 5’-TCT CTT AGT GCT GTG CTC 
ACC-3.The amplified fragments were separated 
on 1 % agarose gel with ethidium bromide 
staining. 
Statistical analysis 
Statistical analysis was performed by using SPSS 
(Statistical Package for Social Science, Version 
16.0) .The Student’s t test was used for 
continuous variables, and the X
2
 test was used for 




     From the 40 hypertensive subjects, 100 % of 
them remained on anti hypertensive therapy. 
Table .1 summarizes the demographic and clinical 
characteristic of all subjects. There were 
significant  differences between two groups with 
respect to age and gender.  
Apart from blood pressure , BMI, diabetes,  
family history and 27 bp polymorphism  were 
significantly higher in cases than in controls 
(P=0.009) . A 420 bp band indicated five repeats 
of the 27 bp (eNOS4b allele), and a 393 bp band 
four repeats (eNOS4a allele) (Fig1).  
 
 
Figure1. Genotype of intron 4 of eNOS gene 27 bp 
polymorphism 
 
The hypertensive patient group showed a 
significant higher frequency of the 4a allele 
compared to the controls (Fig 2). 
 
Table 1. Demographic and clinical characteristics of the study population. 
 Normotensive subjects=40 Hypertensive patients=40 
Age % 44.15 61. 78 
Sex(male) % 65  35   
BMI(kg/m
2
) % 24.78 28.01 
Diabetes % 2.5 22.5 
Smokers % 30 12.5 
Family history % 32.5 57.5 
27 bp polymorphism % 22      47.5  
 
DICSUSSION 
     In the present study, it is found that there is a 
significant correlation between eNOS gene 
polymorphism and the rate of hypertension in 
Iran_tehran population. Our results  showed that 
4a allele frequency of the eNOS gene intron 4a4b 
VNTR polymorphism were  significantly higher 
in patients with hypertension . Some researchers 




have investigated the association between the 
eNOS gene intron 4a4b VNTR polymorphism and 
hypertension, with conflicting results; in 1998, 
Miyamoto et al [16] reported the 894T 
 























Figure2. Distribution of genotype frequency  
 
 
allele was associated with increased risk of 
hypertension in Japanese, whereas Lacolley et al 
[17] claimed that the 894G allele was risk 
associated allele in Caucasians. However, two 
following Japanese studies with relatively large 
sizes did not replicate these positive results, they 
didn’t  reveal any association between the G894T 
polymorphism and hypertension [18,19]. Uwabo 
et al [20] reported that the 4a4b polymorphism 
was correlated with hypertension, which is 
concordant to our study 
The mechanism by which the NOS34a4b 
polymorphism confers susceptibility to 
hypertension hasn’t understood yet. The 4a4b 
polymorphism is associated with altered plasma 
NO levels, influencing both NO and enzyme 
production [21]. According to several studies 
concerning human and experimental 
hypertension, it is exhibited that production of NO 
is decreased the NO-dependent dilatation is 
blunted [22,23]. The main factor for the 
impairment of the NO-cyclic GMP pathway in 
hypertension seems to be located at the level of 
the NOS3. Additional evidences implicated 
dysfunction of NO system in hypertension [23,24] 
with fort et al [1]. Wang et al [24] observed that 
the intron 4b/a coordinated with the T-786C and 
regulated the transcription efficiency in a 
haplotype-specific fashion in vitro experiment. In 
addition,it is  also observed that the haplotype-
specific effects of T-786C and intron 4a/b on the 
eNOS gene promoter efficiency were modified  
by cigarette smoking in vitro experiment. In this 
study, we also examined  whether gender, age, 
BMI, family history and smoking(Table 1) status 
exert influence on the relationship of the three 
eNOS gene polymorphism and all possible 
haplotypes with hypertension by adding 
interaction terms .Although we  did not find any 
significant results ,it  could not excluded  the 
possibility that the eNOS gene variants are 
involved in hypertension within other 
environmental or genetic context. Tanus-santos et 
al [25] observed that the distribution of these three 
eNOS polymorphism frequencies were markedly 




     The present study showed a significant  
association between the eNOS3 gene 
polymorphism and hypertension in the Iran-
Tehran  population .For the future study it is 
necessary to select the other genes which involved 
in hypertension condition .  
 
  





1. Vallance P, Collier J, Moncada S. Effects of 
endothelium-derived nitric oxide on peripheral 
arteriolar tone in man. Lancet 1989; 2:997-1000. 
2. Forte P, Copland M, Smith M, Milne E, 
Sutherland J, Benjamin N, Basal nitric oxide 
synthase in essential hypertension. Lancet 
1997;349;837-42. 
3.Huang PL, Huang Z, Mashimo H, Bloch KD, 
Moskowitz MA, Bevan JA, Fishman MC. 
 Hypertension in mice lacking the gene for 
endothelial nitric oxide synthase .Nature 
1995;377:239-42. 
4. Derebecka N, Holysz M, Trzeciak W.H. Genes 
of nitric oxide synthases: Structure, regulation of 
expression, protein products. Postêpy Biochemii 
2000;  2: 130–139  
5. An P, Freedman BI, Hanis CL, Chen YD, 
Weder AB, Schork NJ, Boerwinkle E, Province 
MA, Hsiung CA, Wu X, Quertermous T, Rao DC. 
Genome-wide linkage scans for fasting glucose, 
insulin, and insulin resistance in the national 
heart, lung, and blood institute family blood 
pressure program: evidence of linkages to 
chromosome 7q36 and 19q13 from meta-analysis. 
Diabetes 2005; 54 (3): 909-14 
6. Stuehr DJ. Structure-function aspects in the 
nitric oxide synthases. Annu Rev Pharmacol 
Toxicol 1997;37:339–5. 
7. Chen, PF, Tsai AL, Berka V,Wu  KK. 
Endothelial nitric oxide synthase. J. Biol. Chem. 
1996; 271: 14631–14635 
8 Marsden  PA, Heng  HHQ, Scherer SW, Stewart 
RJ, Hall  AV, Shi  XM, Tsui LC. Schappert 
KT.Structure and chromosomal localization of the 
human constitutive endothelial nitric oxide 
synthase gene. J. Biol. Chem.1993;268: 17478–
1748 
9.World health organization.International society 
of hypertension guideline for the management of 
hypertension .J hypertens 1999;17:151-183. 
10. Licata G, Scaglione R, Corrao S, Ganguzza A, 
Mazzola G, Arnone S, Dichiara MA, Licata A, 
Merlino G, Di Chiara T. Heredity and obesity 
associated hypertension. Impact of hormonal 
characteristics and left ventricular mass. J 
Hypertens 1995; 13:611-618. 
11. Aras O., Hanson NQ, Bakanay SM, Tsai My, 
Gulec S. Endothelial nitric oxide gene 
polymorphism (Glu298Asp) is not associated with 
coronary artery disease in Turkish population. 
Thromb Haemost. 2002;87(2):347-349. 
12. Cakir DU, Mete N. The role of endothelial 
nitric oxide synthase gene polymorphism  in 
clinically  classified  patients  with coronary 
artery disease. Biotechnology and  
Biotechnological Equipment.2004;4:2117-2121 
13. Ichihara S, Yamada Y, Fujimura T, 
Nakashima N, Yokota M. Association of a 
polymorphism of the endothelial constitutive 
nitric oxide synthase gene with myocardial 
infraction in the Japanese population. Am J 
Cardiol 1998; 18 : 83-6. 
14. Park JE, Lee WH, Hwang TH, Chu JA, Kim 
S, Choi YH, Kim JS, Kim DK, Lee SH, Hong KP, 
Seo JD, Lee WR. Aging affects the association 
between endothelial nitric oxide synthase gene 
polymorphism and acute myocardial infarction in 
the Korean male population. Korean J. Intern. 
2000;15: 65-70. 
15.Wang XL, Sim AS, Bandenhop    RF, 
McGredie RM, Wilken DE. A smoking dependent 
risk of coronary artery disease associated with 
polymorphism of the endothelial nitric oxide 
synthase gene.Nat Med 1996;2: 41-45. 
16.Miyamoto Y, Saito Y, Kaiiyama N, Yoshimura 
M, Shimasaki Y, Nakayama M. Endothelial nitric 
oxide synthase gene is positively associated with 
essential hypertension.hypertension 1998; 32:3-8. 
17.Lacolley P, Gautier S, Poirier O, Pannier B, 
Cambien F, Benetons A.Nitric oxide synthase 
gene polymorphism, blood pressure and aortic 
stiffness in normotensive and hypertensive 
subjects. J Hypertens 1998;16;31-35. 
18.Kato N, Sugiyama T, Morita H, Nabika T, 
Kurihara H, Yamori Y. Lack of evidence for 
association between the endothelial nitric oxide 
synthase gene and hypertension.hypertension 
1999;33;933-936. 
19.Tsujita y, Baba S, Yamauchi R, Mannami T, 
Kinoshita M, Yamamoto R. Association analyses 
between genetic polymorphism of endothelial 
nitric oxide synthase gene and hypertension in 
Japanese: The Suita study. J Hypertens 
2001;19:1941-1948. 




20.Uwabo J, Soma M, Nakayama T, Kanmatsuse 
K. Association of a variable number of tandem 
repeats in the endothelial constitutive nitric oxide 
synthase gene with essential hypertension in 
Japanese.Am J hypertens 1998;11:125-8. 
21.Tsukada T, Yokoyama K, Arai T, et al. 
Evidence of association of the eNOS gene 
polymorphism with plasma NO metabolite 
concentration in humans. Biochem Biophys Red 
Commun 1998;245: 190-3. 
22.Linder L, Kiowski W, Buhler FR, Lucher T. 
Indirect evidence for release of endothelium-
derived relaxing factor in human foream 
circulation in vivo:blunted response in essential 
hypertension. Circulation 1990;81:1762-7. 
23.Lucher TF, Raji L, Vanhoutte P. Endothelium-
dependent vascular responses in normotensive 































24.Wang J, Dudley D, Wang XL. Haplotype-
specific effects on endothelial NO sysnthase 
promoter efficiency:modifiable by cigarette 
smoking. Arterioscler thrombvasc Bio 2002;22:el-
4. 
25.Tanus-Santos JE, Desai M, Flockhart DA. 
Effects of ethnicity on the distribution of 
clinically relevant endothelial nitric oxide  
variants. Pharmacogenetics 2001;11:719-725. 
